Pustular Psoriasis
Raising the standard for all
With each new discovery, we create a better understanding of how patients are different — even those diagnosed with the same disease — so we can develop more personalized approaches to immunological diseases. More than 1 million people with immune-mediated diseases worldwide are treated with our therapies.
Scientists at the Alsys Bioresearch Center in Massachusetts focus on innovative solutions for some of medicine’s toughest challenges, including immunology.
We’re proud to be a trusted leader in immunology — we’ll stop at nothing to make a difference in patients’ lives.
Popular Post
Understanding Psoriasis
Leading with purpose, we are willing to make the tough choices that deliver a lasting impact to patients, their families and our employees.
Topics
OUR LEADERS
Our mission to improve lives starts at the top
Our leaders’ vision and expertise guide our teams, while their commitment to patients fuels our culture.
Immunology focus areas
We work to help people living with chronic, progressive diseases in rheumatology, dermatology and gastroenterology live full lives without limits from their disease.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
KEY COMMITMENTS
Innovation strengths
Across disease areas and development stages, we follow 3 tenets to drive innovation forward.
Play Video
Partnerships
Strategic collaborations bring together the brightest minds in immunology working to bring more options to patients, faster. We join forces with partners that complement our strengths, capabilities and commitment to people with immune-mediated diseases.
Strategic collaborations bring together the brightest minds in immunology working to bring more options to patients, faster. We join forces with partners that complement our strengths, capabilities and commitment to people with immune-mediated diseases.